Información de la revista
Sección: artículo original
Acceso a texto completo
Pruebas previas, online el 3 de diciembre de 2025
Incidence and survival of cutaneous squamous cell carcinoma. A Spanish multicenter population-based study
Visitas
98
N.F. Fernández-Martínez1,2,3, D. Redondo-Sánchez1,2,3,
Autor para correspondencia
, A. Ameijide4,5, M. Carulla4,5, J. Rubió-Casadevall6, R. Marcos-Gragera1,7,8,9,10, M. Guevara1,11,12, A. Gasque11, I. García-Doval13, S. Arias-Santiago2,14, J. Galceran4,5, M.J. Sánchez1,2,3
1 CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
2 Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
3 Escuela Andaluza de Salud Pública, Granada, Spain
4 Registro de Cáncer de Tarragona, Servicio de Epidemiología y Prevención del Cáncer, Hospital Universitari Sant Joan de Reus, Reus, Spain
5 Pere Virgili Health Research Institute (IISPV), Reus, Spain
6 Medical Oncology Department. Catalan Institute of Oncology, Girona, Spain
7 Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Spain
8 Girona Biomedical Research Institute (IDIBGI-CERCA), Girona, Spain
9 Josep Carreras Leukemia Research Institute, Badalona, Spain
10 Department of Medical Sciences, Medical School, University of Girona, Girona, Spain
11 Instituto de Salud Pública y Laboral de Navarra, 31003 Pamplona, Spain
12 Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain
13 Unidad de Investigación de la Academia Española de Dermatología y Venereología, Madrid, Spain
14 Hospital Universitario Virgen de las Nieves, Granada, Spain
Ver más
Este artículo ha recibido
Información del artículo
ABSTRACT

Background: Cutaneous squamous cell carcinoma (cSCC) constitutes a serious public health problem, as it is the 2nd most frequent skin cancer. Few studies have assessed epidemiological indicators of cSCC in Southern Europe. The objectives of this study were to analyze its incidence rate and estimate survival of cSCC cases from all Spanish population-based cancer registries that register this cancer.

Materials and methods: We conducted a retrospective descriptive study of all incident first cSCC cases registered in Girona, Granada, Navarre and Tarragona (Spain) from 1994 through 2017. Crude and age-standardized (ASR-E) incidence rates were calculated. Incidence trends were analyzed using joinpoint regression. Observed survival was estimated using the Kaplain-Meier method and relative survival was estimated using the Ederer II method.

Results: A total of 22,343 cSCC cases (61.5% men) were registered, accounting for 20.3% of all skin cancers. The most common anatomical site was the skin of face, scalp and neck (59.1%) and the incidence rate increased exponentially with age. The annual ASR-E per 100,000 inhabitants was 25.0 in women and 56.6 in men. Both sexes showed a significant upward incidence trend, with an annual percent change of +2.0% (95%CI, +1.6%–+2.4%). The 5-year relative survival rate was 93.5% (95%CI, 92.5%-94.6%), slightly higher in women, and did not seem to increase over time.

Conclusions: This study provides an updated description of cSCC incidence and survival, which are key indicators to frame the scenario of this cancer in Spain. Overall, results are consistent with former studies, showing a rising trend in the incidence rate alongside high survival rates. Further research is warranted to elucidate the causes underlying these findings.

Keywords:
squamous cell carcinoma
epidemiology
incidence
survival
public health monitorization
El Texto completo está disponible en PDF
Copyright © 2025. AEDV
Descargar PDF
Idiomas
Actas Dermo-Sifiliográficas
Opciones de artículo
Herramientas